id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1972-0010,FDA,FDA-2019-E-1972,Letter and Certificate from U.S. Patent and Trademark Office to Eli Lilly and Company,Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-02-28T20:56:02Z,,0,0,090000648641df68
FDA-2019-E-1972-0009,FDA,FDA-2019-E-1972,Notice of Final Determination Letter,Other,Letter(s),2024-02-21T05:00:00Z,2024,2,2024-02-21T05:00:00Z,,2024-02-21T21:49:15Z,,0,0,09000064863eea1a
FDA-2019-E-1972-0008,FDA,FDA-2019-E-1972,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-17T05:00:00Z,2024,1,2024-01-17T05:00:00Z,,2024-01-17T19:20:52Z,,0,0,090000648639028e